WASHINGTON (AP) — A division of Johnson & Johnson has asked federal regulators to grant full approval to an HIV drug designed to treat patients who have stopped responding to other treatments.
The Food and Drug Administration gave Intelence preliminary approval in January under its accelerated approval program, which allowed J&J to market the drug. In order to gain full approval, FDA required the company to submit follow-up data on the drug’s Read the rest of this entry »

A scathing report by the Health and Disability Commissioner says a travelling men's sexual health clinic that regularly visits Nelson came close to exploiting four men it treated.
Between February and June last year Commissioner Ron Paterson received four complaints about the New Zealand Men's Clinic, from men in various parts of the country from Whangarei to Dunedin.
The clinic, which regularly advertises in
and claims a 95 per cent Read the rest of this entry »

Many people know that the Federal Reserve sets interest rates in order to loan money to other banks so they can keep cash
flowing throughout the U.S. financial system. Mostly, this works great for everyone involved. But, sometimes, banks and thrifts
need a little extra cash, mostly so they can meet the reserve requirement (the minimum amount of deposits banks need to be
considered in good financial shape).
Read the rest of this entry »

A drug used for stroke patients may help sharpen middle-aged brains, researchers are reporting.
In the latest development in the quest for cognitive enhancers, researchers found the drug Fasudil significantly improves learning and memory in middle-aged rats.
If proven in humans, the drug may one day help blunt the impact of normal aging “or even enhance learning and memory throughout the life span,” the American Psychological Association said Read the rest of this entry »

Washington, D.C. – infoZine – The U.S. Food and Drug Administration licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.
People with congenital fibrinogen deficiency are unable to make sufficient amounts of fibrinogen, which plays an important role in blood coagulation Read the rest of this entry »

NEW BRUNSWICK, N.J.
Johnson & Johnson said Wednesday the U.S. Food and Drug Administration rejected its new-drug application for ceftobiprole, an antibiotic for the treatment of complicated skin and skin-structure infections, including diabetic-foot infections.
J&J’s Pharmaceutical Research & Development unit said the FDA in a letter said the company needs to conduct additional audit work of clinical-investigator sites and to address specific Read the rest of this entry »

Posted on: Monday, 15 December 2008, 08:41 CST
Menopause hormones can increase the danger of breast cancer, says a new study that discloses impressive evidence of the concerns of these popular pills.
The study also says that women who took estrogen and progestin pills for a little while also had a better chance of contracting cancer.
It is obvious that breast cancer numbers decreased in recent years largely because women stopped hormone therapy Read the rest of this entry »

HARARE (AFP) — Zimbabwe’s high court on Friday refused a request by a top rights activist detained on accusations of plotting to overthrow the government to be taken to hospital for treatment after alleged torture — contradicting an earlier order by the same court.
“The judge (Alphius Chitakunye) made the incredible order that if she should be taken to hospital it would be for purposes of examination otherwise she would be treated in prison,” Read the rest of this entry »

next to the proton therapy radiation center the hospital is building with the private company ProCure.
The 48,000-square-foot cancer treatment center will cost $35.5 million. It will offer patients all cancer treatment services including radiation therapy and chemotherapy and supporting services such as diagnostic imaging, nutritional counseling and social work.
The Winfield-based hospital recently entered into a 10-year clinical affiliation with Read the rest of this entry »

WASHINGTON (AP) — A division of Johnson & Johnson has asked federal regulators to grant full approval to an HIV drug designed to treat patients who have stopped responding to other treatments.
The Food and Drug Administration gave Intelence preliminary approval in January under its accelerated approval program, which allowed J&J to market the drug. In order to gain full approval, FDA required the company to submit follow-up data on the drug’s Read the rest of this entry »